Fujian Cosunter Pharmaceutical Co., Ltd.

Share · CNE100001YZ0 (XSHE)

Overview

No Price

Closing Price XSHE 28.01.2026: 105,01 CNY

28.01.2026 07:06

Current Prices from Fujian Cosunter Pharmaceutical Co., Ltd.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
SHENZHEN STOCK EXCHANGE	300436.SZ	CNY	28.01.2026 07:06	105,01 CNY	12,90 CNY +14,00 %

Share Float & Liquidity

Free Float 71,70 %

Shares Float 114,2 M

Shares Outstanding 159,27 M

Company Profile for Fujian Cosunter Pharmaceutical Co., Ltd. Share

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers Chinese patent medicines in the areas of liver diseases, andrology, cardiovascular, and other fields. The company was founded in 2001 and is based in Fuzhou, China.

AI Analysis of Fujian Cosunter Pharmaceutical Co., Ltd.

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Fujian Cosunter Pharmaceutical Co., Ltd.

No AI threads available for this company yet.

Company Data

Name Fujian Cosunter Pharmaceutical Co., Ltd.

Company Fujian Cosunter Pharmaceutical Co., Ltd.

Website https://www.cosunter.com

Primary Exchange

SHENZHEN STOCK EXCHANGE

ISIN CNE100001YZ0

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO Guoping Li

Market Capitalization 15 Mrd.

Country China

Currency CNY

Employees 0,9 T

Address Software Park, Building 10, 350003 Fuzhou

IPO Date 2015-05-04

Ticker Symbols

Name	Symbol
SHENZHEN STOCK EXCHANGE	300436.SZ

More Shares

Investors who hold Fujian Cosunter Pharmaceutical Co., Ltd. also have the following shares in their portfolio:

KG + BAUER AG ST Share

PROMOS TECHNOLOGIES INC - GDS(REPR 10 COM SHS TWD10)(REG S) Depository Receipt

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog